Deficiency of NF‐Erythroid 2‐Related Factor 2 Exacerbates the Scar Through ERK Signaling Pathway
Immunity, Inflammation and Disease · 2026-02 · 14 (2)
DOI: 10.1002/iid3.70361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 23.02.2026. Verfasst von Xueyuan Hao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Cicatrix, MAP Kinase Signaling System. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Scar, primarily composed of poorly structured and disordered collagen, is mainly characterized by excessive fibroblast activation and abnormal collagen deposition. Previous studies have shown that fibroblast activation is closely related to the imbalance of inflammatory responses and reactive oxygen species. NF‐erythroid 2–related factor 2 (Nrf2) is an important transcription factor involved in regulating inflammation and oxidative stress. Although current evidence suggests that Nrf2 influences the occurrence of skin fibrosis, the role of Nrf2 in scar formation remains unknown.
Methods
In this study, we used qRT‐PCR, Western Blot, and Immunohistochemical/Immunofluorescent staining to explore the role of Nrf2 in wound healing and scar formation.
Results
The deficiency of Nrf2 delayed the process of wound healing and exacerbated collagen deposition. Moreover, significant elevations in the mRNA expression of collagen synthesis‐related genes were observed in Nrf2‐deficient mice in vivo and in vitro. Meanwhile, Nrf2 deficiency also exacerbated inflammatory responses, leading to abnormal fibroblast activation and sustained activation of the ERK signaling pathway.
Conclusion
These results suggest that Nrf2 plays a crucial role in fibroblast activation and scar formation, and our findings offer a novel therapeutic approach for reducing scar formation after skin injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China.
- Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, Hongqiao District, China.
- College of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
- Department of Ophthalmology, Second Hospital of Tianjin Medical University, Tianjin, China.
ORCID-Profile: Mengke Sun, Jing Luo, Lizhi Hu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hao, X., Sun, M., Wang, R., Chen, H., Huang, J., Luo, J., Yu, H., Li, Y., Xing, W., Li, X., & Hu, L. (2026). Deficiency of NF‐Erythroid 2‐Related Factor 2 Exacerbates the Scar Through ERK Signaling Pathway. Immunity, Inflammation and Disease, 14(2). https://doi.org/10.1002/iid3.70361
Vancouver
Hao X, Sun M, Wang R, Chen H, Huang J, Luo J, et al. Deficiency of NF‐Erythroid 2‐Related Factor 2 Exacerbates the Scar Through ERK Signaling Pathway. Immunity, Inflammation and Disease. 2026;14(2). doi:10.1002/iid3.70361
BibTeX
@article{Hao2026,
author = {Hao, Xueyuan and Sun, Mengke and Wang, Ruotong and Chen, Hong and Huang, Junkai and Luo, Jing and Yu, Haoyue and Li, Yingxi and Xing, Weibin and Li, Xiaoxia and Hu, Lizhi},
title = {Deficiency of NF‐Erythroid 2‐Related Factor 2 Exacerbates the Scar Through ERK Signaling Pathway},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {2},
doi = {10.1002/iid3.70361}
}
EUVIMED